Pursuant to PIT (Regulation), 2015 the Trading window shall remain closed from 01st October, 2026 till 48 hours after the declaration of unaudited financial result for the quarter and Half -Year ended 30th September, 2026.

J O H N S O N PHARMACARE LIMITED CIN: L51100GJ1994PLC022388 Registered & Corp. Office Address - I-460, Fourth Floor, Titanium City Centre Mall, Near Sachin Tower, Anand Nagar Road, Satellite, Ahmedabad-380015 Email id: johnsonpharmacare1994@gmail.com sunandshineworldwideltd@gmail.com Date: 26.09.2026 The Manager The Department of Corporate Service BSE Limited P.J. Towers, Dalal Street, Mumbai-400001 BSE Scrip Code: 532154 ISIN: INE560F01022 Subject: Intimation of Closure of trading window as per Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 for the quarter and half year ended on 30th September, 2026. Dear Sir/ Ma’am, Pursuant to Company’s Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, we would like to inform you that the trading window of the Company shall remain closed for all Designated Persons and specified Connected Person of the Company to deal in Securities of the Company shall remain closed from 1st October 2026, till the completion of 48 hours after the declaration of un-audited Financial Results of the Company for the quarter and half year ended 30th September, 2026. The Date of consideration of un-audited Financial Results for the quarter and half year ended 30th September, 2026 shall be intimated in due course of time. This is for your kind Information and record please. For and on behalf of Board of Directors of Johnson Pharmacare Limited Nand Kishor Ray (Additional Director) DIN: 11626638 Date: 26.09.2026 Place: Gujarat